Ophthalmology Grand Rounds
| When |
October 27, 2023
7 a.m. to 8 a.m.
|
|---|---|
| Where |
When it's time, join your Webex meeting here. Phone (audio only): Mobile phone (one-touch): |
| Contact Information |
Target audience: Ophthalmologists and ophthalmologists in training.
Topic: AMD in 2023
Speaker: Thomas Hwang, M.D.
Learning objectives
- Evaluate the evidence for the new treatments for geographic atrophy and wet macular degeneration.
- Assess the clinical trial treatment protocols for applicability in a real-world setting.
- Analyze the value of the new treatments in light of the cost and the benefit to the patients.
Accreditation
Oregon Health & Science University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credits
OHSU School of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure to Learners
Presenters/Moderators
- Thomas Hwang, M.D. - Nothing to Disclose
Program Planning Committee
- Hemakshi Adke - Nothing to Disclose
- Aiyin Chen, M.D. - Nothing to Disclose
- Julie Falardeau, M.D. - Nothing to Disclose
- Seema Gupta, M.D. - Nothing to Disclose
- Brooke Harkness, O.D. - Nothing to Disclose
- Thomas Hwang, M.D. - Nothing to Disclose
- Susan Minnieweather - Nothing to Disclose
- Afshan Nanji, M.D. - Nothing to Disclose
- Amanda Redfern, M.D. - Nothing to Disclose
- Leah Reznick, M.D. - Nothing to Disclose
- Daniel Tu, M.D., Ph.D. - Nothing to Disclose
- Lorri Wilson, M.D. - Nothing to Disclose